Skip to main content
Premium Trial:

Request an Annual Quote

Affitech, Norwegian Radium Hospital Awarded $900K Immunoproteomics Grant

NEW YORK, Feb. 17 (GenomeWeb News) - Affitech, an Oslo, Norway-based antibody discovery firm, said today that Norway's FUGE (Functional Genomics) funding program has awarded it a NOK 6.2 million ($900,000) grant to support a collaborative research project with the Norwegian Radium Hospital.

The award will fund research that Affitech and the hospital began several years ago in the area of cancer immunoproteomics. Researchers from the two organizations are working together to develop techniques to identify tumor-specific or tumor-associated antigens and antibodies.

Affitech said it plans to use human antibodies against tumor-associated antigens to directly attack tumors, while the research team at the Norwegian Radium Hospital will use tumor antigens to stimulate the T-cell dependent arm of the immune system with the goal of creating a cancer vaccine.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.